Regarding renal failure, our results showed that adverse events associated with renal function deterioration (ESKD and CRD) and renal replacement therapy (dialysis, renal transplant) were accumulated among the 30–70-year-old patients with deleterious mutations in COL4A3/4. Here, COL4A3 is linked to Renal insufficiency.